News Headlines Article

Report notes CMS drug overpayments; potential savings seen in new pricing initiative
Modern Healthcare

A routine market analysis by HHS investigators concluded that the CMS overpaid for medications in a recent quarter by $4.6 million. However, Medicare could recoup nearly as much through a coming market-pricing initiative. Stuart Wright, deputy inspector general at HHS, wrote Marilyn Tavenner, acting CMS administrator, on Aug. 10 with his office’s quarterly estimate of the excessive drug prices the agency had paid in a preceding quarter.